Fiche du document
27 août 2021
- doi: 10.1007/s11892-021-01399-z
- issn: 1534-4827
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s11892-021-01399-z
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34448957
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1539-0829
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_FB26E89F8D174
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Mots-clés
Atkins diet; Glucose intolerance; Keto; Ketogenic diet; Type 2 diabetes; Very-low-carb dietSujets proches
Type II diabetes Ketosis resistant diabetes Adult onset diabetes Noninsulin-dependent diabetes NIDDM (Diabetes) Stable diabetes Maturity onset diabetes Type 2 diabetes dietCiter ce document
D. Tinguely et al., « Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review. », Serveur académique Lausannois, ID : 10.1007/s11892-021-01399-z
Métriques
Partage / Export
Résumé
To assess the pleiotropic effects of ketogenic diets (KD) on glucose control, changes in medication, and weight loss in individuals with type 2 diabetes, and to evaluate its practical feasibility RECENT FINDINGS: KD results in improved HbA1c already after 3 weeks, and the effect seems to persist for at least 1 year. This is associated with a reduction in glucose-lowering medications. The weight loss observed after a short time period seems to be maintained with a long-term diet. Adequate support (supportive psychological counseling, enhancing positive affectivity, reinforcing mindful eating) is necessary to achieve a benefit and to assure adherence. Despite the documented decrease in HbA1, a definitive causal effect of KD remains to be proven. KD should be performed under strict medical supervision. Future research should clarify how compliance can be maximized and how ketosis can be optimally monitored.